{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:28:59Z","timestamp":1791473339520,"version":"4.3.4"},"reference-count":202,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Melatonin is a neurohormone that is mainly secreted by the pineal gland. It coordinates the work of the superior biological clock and consequently affects many processes in the human body. Disorders of the waking and sleeping period result in nervous system imbalance and generate metabolic and endocrine derangements. The purpose of this review is to provide information regarding the potential benefits of melatonin use, particularly in kidney diseases. The impact on the cardiovascular system, diabetes, and homeostasis causes melatonin to be indirectly connected to kidney function and quality of life in people with chronic kidney disease. Moreover, there are numerous reports showing that melatonin plays a role as an antioxidant, free radical scavenger, and cytoprotective agent. This means that the supplementation of melatonin can be helpful in almost every type of kidney injury because inflammation, apoptosis, and oxidative stress occur, regardless of the mechanism. The administration of melatonin has a renoprotective effect and inhibits the progression of complications connected to renal failure. It is very important that exogenous melatonin supplementation is well tolerated and that the number of side effects caused by this type of treatment is low.<\/jats:p>","DOI":"10.3390\/cells12060838","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T03:03:23Z","timestamp":1678331003000},"page":"838","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Melatonin Treatment in Kidney Diseases"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8015-872X","authenticated-orcid":false,"given":"Magdalena","family":"Markowska","sequence":"first","affiliation":[{"name":"Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine, 128 Szaser\u00f3w Street, 04-141 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanis\u0142aw","family":"Niemczyk","sequence":"additional","affiliation":[{"name":"Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine, 128 Szaser\u00f3w Street, 04-141 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1447-2917","authenticated-orcid":false,"given":"Katarzyna","family":"Romejko","sequence":"additional","affiliation":[{"name":"Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine, 128 Szaser\u00f3w Street, 04-141 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/biof.23","article-title":"Melatonin: Signaling mechanisms of a pleiotropic agent","volume":"35","author":"Hardeland","year":"2009","journal-title":"Biofactors"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Vasey, C., McBride, J., and Penta, K. (2021). Circadian Rhythm Dysregulation and Restoration: The Role of Melatonin. Nutrients, 13.","DOI":"10.3390\/nu13103480"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e12728","DOI":"10.1111\/jpi.12728","article-title":"Mitochondrial function is controlled by melatonin and its metabolites in vitro in human melanoma cells","volume":"70","author":"Bilska","year":"2021","journal-title":"J. Pineal Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e12610","DOI":"10.1111\/jpi.12610","article-title":"Melatonin exerts oncostatic capacity and decreases melanogenesis in human MNT-1 melanoma cells","volume":"67","author":"Kim","year":"2019","journal-title":"J. Pineal Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"18886","DOI":"10.3390\/molecules201018886","article-title":"Melatonin as a Potent and Inducible Endogenous Antioxidant: Synthesis and Metabolism","volume":"20","author":"Tan","year":"2015","journal-title":"Molecules"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e12677","DOI":"10.1111\/jpi.12677","article-title":"Switching diseased cells from cytosolic aerobic glycolysis to mitochondrial oxidative phosphorylation: A metabolic rhythm regulated by melatonin?","volume":"70","author":"Reiter","year":"2021","journal-title":"J. Pineal Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1007\/s00018-019-03438-1","article-title":"Melatonin inhibits Warburg-dependent cancer by redirecting glucose oxidation to the mitochondria: A mechanistic hypothesis","volume":"77","author":"Reiter","year":"2020","journal-title":"Cell Mol. Life Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00018-021-04102-3","article-title":"Melatonin: Highlighting its use as a potential treatment for SARS-CoV-2 infection","volume":"79","author":"Reiter","year":"2022","journal-title":"Cell Mol. Life Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0301-0082(98)00052-5","article-title":"Oxidative damage in the central nervous system: Protection by melatonin","volume":"56","author":"Reiter","year":"1998","journal-title":"Prog. Neurobiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jid.2017.10.025","article-title":"Melatonin: A Cutaneous Perspective on its Production, Metabolism, and Functions","volume":"138","author":"Slominski","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e12626","DOI":"10.1111\/jpi.12626","article-title":"Characterization of serotonin and N-acetylserotonin systems in the human epidermis and skin cells","volume":"68","author":"Slominski","year":"2020","journal-title":"J. Pineal Res."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Bocheva, G., Slominski, R.M., Janjetovic, Z., Kim, T.K., B\u00f6hm, M., Steinbrink, K., Reiter, R.J., Kleszczy\u0144ski, K., and Slominski, A.T. (2022). Protective Role of Melatonin and Its Metabolites in Skin Aging. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031238"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1385\/ENDO:27:2:119","article-title":"Antioxidative protection by melatonin: Multiplicity of mechanisms from radical detoxification to radical avoidance","volume":"27","author":"Hardeland","year":"2005","journal-title":"Endocrine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"112001","DOI":"10.1016\/j.biopha.2021.112001","article-title":"Roles of melatonin in the field of reproductive medicine","volume":"144","author":"Yong","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/s41418-021-00919-4","article-title":"Circadian rhythm modulates endochondral bone formation via MTR1\/AMPK\u03b21\/BMAL1 signaling axis","volume":"29","author":"Yu","year":"2022","journal-title":"Cell Death Differ."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"826660","DOI":"10.3389\/fendo.2022.826660","article-title":"Melatonin Accelerates Osteoporotic Bone Defect Repair by Promoting Osteogenesis-Angiogenesis Coupling","volume":"13","author":"Zheng","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2174\/1570159X14666161228122115","article-title":"Melatonin: Pharmacology, Functions and Therapeutic Benefits","volume":"15","author":"Tordjman","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"ref_18","first-page":"7","article-title":"Kidney protective effects of melatonin","volume":"3","author":"Tavakoli","year":"2014","journal-title":"J. Nephropharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4103\/2230-8210.93735","article-title":"The reno-pineal axis: A novel role for melatonin","volume":"16","author":"Kalra","year":"2012","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"692022","DOI":"10.3389\/fimmu.2021.692022","article-title":"Exosomes and Melatonin: Where Their Destinies Intersect","volume":"12","author":"Novais","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1021\/ja01543a060","article-title":"Isolation of Melatonin, the Pineal Gland Factor That Lightens Melanocytes","volume":"80","author":"Lerner","year":"1958","journal-title":"J. Am. Chem. Soc."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0987-7053(96)84908-2","article-title":"Melatonin in humans: A biochemical marker of the circadian clock and an endogenous synchronizer","volume":"25","author":"Claustrat","year":"1995","journal-title":"Neurophysiol. Clin."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.smrv.2004.08.001","article-title":"The basic physiology and pathophysiology of melatonin","volume":"9","author":"Claustrat","year":"2005","journal-title":"Sleep Med. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1080\/00207454.2019.1692838","article-title":"Revisiting the pineal gland: A review of calcification, masses, precocious puberty, and melatonin functions","volume":"130","author":"Patel","year":"2020","journal-title":"Int. J. Neurosci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuchi.2015.03.002","article-title":"Melatonin: Physiological effects in humans","volume":"61","author":"Claustrat","year":"2015","journal-title":"Neurochirurgie"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1210\/er.2018-00084","article-title":"Melatonin as a Hormone: New Physiological and Clinical Insights","volume":"39","year":"2018","journal-title":"Endocr. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/B978-0-12-405210-9.00006-0","article-title":"Role of melatonin and its receptors in the vertebrate retina","volume":"300","author":"Wiechmann","year":"2013","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000109491","article-title":"Melatonin and its receptors in the gastrointestinal tract","volume":"2","author":"Lee","year":"1993","journal-title":"Biol. Signals"},{"key":"ref_29","first-page":"23","article-title":"Role of melatonin in upper gastrointestinal tract","volume":"58","author":"Konturek","year":"2007","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.stem.2018.08.002","article-title":"Daily Onset of Light and Darkness Differentially Controls Hematopoietic Stem Cell Differentiation and Maintenance","volume":"23","author":"Golan","year":"2018","journal-title":"Cell Stem Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.biopha.2006.01.002","article-title":"Melatonin receptors in humans: Biological role and clinical relevance","volume":"60","author":"Ekmekcioglu","year":"2006","journal-title":"Biomed. Pharmacother."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1111\/bph.13950","article-title":"Melatonin receptors: Molecular pharmacology and signalling in the context of system bias","volume":"175","author":"Cecon","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00109-020-02023-5","article-title":"MT1 and MT2 melatonin receptors play opposite roles in brain cancer progression","volume":"99","author":"Kinker","year":"2021","journal-title":"J. Mol. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1385\/ENDO:27:2:101","article-title":"Functional MT1 and MT2 melatonin receptors in mammals","volume":"27","author":"Dubocovich","year":"2005","journal-title":"Endocrine"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev-pharmtox-010814-124742","article-title":"MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective","volume":"56","author":"Liu","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1007\/s11064-022-03646-5","article-title":"Melatonergic Receptors (Mt1\/Mt2) as a Potential Additional Target of Novel Drugs for Depression","volume":"47","author":"Boiko","year":"2022","journal-title":"Neurochem. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12640-012-9337-4","article-title":"Melatonin antioxidative defense: Therapeutical implications for aging and neurodegenerative processes","volume":"23","author":"BaHammam","year":"2013","journal-title":"Neurotox. Res."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Won, E., Na, K.S., and Kim, Y.K. (2021). Associations between Melatonin, Neuroinflammation, and Brain Alterations in Depression. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010305"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12975-017-0559-x","article-title":"Melatonin Alleviates Intracerebral Hemorrhage-Induced Secondary Brain Injury in Rats via Suppressing Apoptosis, Inflammation, Oxidative Stress, DNA Damage, and Mitochondria Injury","volume":"9","author":"Wang","year":"2018","journal-title":"Transl. Stroke Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/jcp.27084","article-title":"Melatonin, a calpain inhibitor in the central nervous system: Current status and future perspectives","volume":"234","author":"Tamtaji","year":"2019","journal-title":"J. Cell Physiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1469-185X.2009.00118.x","article-title":"The changing biological roles of melatonin during evolution: From an antioxidant to signals of darkness, sexual selection and fitness","volume":"85","author":"Tan","year":"2010","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000156470","article-title":"Melatonin and the immune system in aging","volume":"15","author":"Cardinali","year":"2008","journal-title":"Neuroimmunomodulation"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1600-079X.2003.00105.x","article-title":"Melatonin and viral infections","volume":"36","author":"Bonilla","year":"2004","journal-title":"J. Pineal Res."},{"key":"ref_44","first-page":"423","article-title":"The modulatory role of melatonin on immune responsiveness","volume":"7","author":"Reiter","year":"2006","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.actatropica.2014.04.021","article-title":"Effects of melatonin on oxidative stress, and resistance to bacterial, parasitic, and viral infections: A review","volume":"137","author":"Vielma","year":"2014","journal-title":"Acta Trop."},{"key":"ref_46","first-page":"373","article-title":"The universal nature, unequal distribution and antioxidant functions of melatonin and its derivatives","volume":"13","author":"Reiter","year":"2013","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1600-079X.2005.00265.x","article-title":"Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: Regulation of pro-\/anti-inflammatory cytokine network, protection against oxidative damage and anti-apoptotic effects","volume":"39","author":"Lardone","year":"2005","journal-title":"J. Pineal Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"8638","DOI":"10.3390\/ijms14048638","article-title":"Melatonin: Buffering the immune system","volume":"14","author":"Lardone","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"198108","DOI":"10.1016\/j.virusres.2020.198108","article-title":"Melatonin potentials against viral infections including COVID-19: Current evidence and new findings","volume":"287","author":"BahrampourJuybari","year":"2020","journal-title":"Virus Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"8229","DOI":"10.1007\/s11033-020-05830-8","article-title":"Role of melatonin in the treatment of COVID-19; as an adjuvant through cluster differentiation 147 (CD147)","volume":"47","author":"Sehirli","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1023\/A:1020107915919","article-title":"Gastrointestinal melatonin: Localization, function, and clinical relevance","volume":"47","author":"Bubenik","year":"2002","journal-title":"Dig. Dis. Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000046903","article-title":"Localization, physiological significance and possible clinical implication of gastrointestinal melatonin","volume":"10","author":"Bubenik","year":"2001","journal-title":"Biol. Signals Recept."},{"key":"ref_53","first-page":"381","article-title":"Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT)","volume":"58","author":"Konturek","year":"2007","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_54","first-page":"139","article-title":"Gut clock: Implication of circadian rhythms in the gastrointestinal tract","volume":"62","author":"Konturek","year":"2011","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3892\/etm.2022.11197","article-title":"Role of melatonin in respiratory diseases (Review)","volume":"23","author":"Li","year":"2022","journal-title":"Exp. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-079X.1998.tb00380.x","article-title":"Inhibition of cell proliferation: A mechanism likely to mediate the prevention of neuronal cell death by melatonin","volume":"25","author":"Mayo","year":"1998","journal-title":"J. Pineal Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/jpi.12261","article-title":"HDAC1 inhibition by melatonin leads to suppression of lung adenocarcinoma cells via induction of oxidative stress and activation of apoptotic pathways","volume":"59","author":"Fan","year":"2015","journal-title":"J. Pineal Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.mvr.2013.02.008","article-title":"Antiangiogenic effects of melatonin in endothelial cell cultures","volume":"87","author":"Cos","year":"2013","journal-title":"Microvasc. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1600-079X.2005.00229.x","article-title":"Melatonin limits lung injury in bleomycin treated mice","volume":"39","author":"Genovese","year":"2005","journal-title":"J. Pineal Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"104337","DOI":"10.1016\/j.phrs.2019.104337","article-title":"The usefulness of melatonin in the field of obstetrics and gynecology","volume":"147","author":"Genario","year":"2019","journal-title":"Pharm. Res."},{"key":"ref_61","first-page":"825802","article-title":"Circadian System and Melatonin Hormone: Risk Factors for Complications during Pregnancy","volume":"2015","author":"Valenzuela","year":"2015","journal-title":"Obs. Int."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/14767058.2011.573827","article-title":"Potential utility of melatonin as an antioxidant during pregnancy and in the perinatal period","volume":"25","author":"Aversa","year":"2012","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Minich, D.M., Henning, M., Darley, C., Fahoum, M., Schuler, C.B., and Frame, J. (2022). Is Melatonin the \"Next Vitamin D\"?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements. Nutrients, 14.","DOI":"10.3390\/nu14193934"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Ivanov, D.O., Evsyukova, I.I., Mironova, E.S., Polyakova, V.O., Kvetnoy, I.M., and Nasyrov, R.A. (2021). Maternal Melatonin Deficiency Leads to Endocrine Pathologies in Children in Early Ontogenesis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22042058"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"s03","DOI":"10.1590\/1806-9282.66.s1.3","article-title":"Chronic Kidney Disease","volume":"66","author":"Ammirati","year":"2020","journal-title":"Rev. Assoc. Med. Bras."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00108-017-0195-2","article-title":"Diagnosis and treatment of chronic kidney disease","volume":"58","author":"Girndt","year":"2017","journal-title":"Internist"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Romejko, K., Rymarz, A., Sadownik, H., and Niemczyk, S. (2022). Testosterone Deficiency as One of the Major Endocrine Disorders in Chronic Kidney Disease. Nutrients, 14.","DOI":"10.3390\/nu14163438"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.2741\/4075","article-title":"The role of melatonin treatment in chronic kidney disease","volume":"17","author":"Russcher","year":"2012","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"224","DOI":"10.5527\/wjn.v5.i3.224","article-title":"Sleep disorders and chronic kidney disease","volume":"5","author":"Maung","year":"2016","journal-title":"World J. Nephrol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/smrv.2001.0240","article-title":"Sleep disturbances in dialysis patients","volume":"7","author":"Parker","year":"2003","journal-title":"Sleep Med. Rev."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1525-139X.2006.00116.x","article-title":"Diagnosis and management of insomnia in dialysis patients","volume":"19","author":"Novak","year":"2006","journal-title":"Semin. Dial."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/ndt\/gfi144","article-title":"Sleep disorders in patients with end-stage renal disease undergoing dialysis therapy","volume":"21","author":"Merlino","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_73","first-page":"CD004542","article-title":"Psychosocial interventions for preventing and treating depression in dialysis patients","volume":"12","author":"Natale","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_74","first-page":"CD004542","article-title":"Psychosocial interventions for depression in dialysis patients","volume":"3","author":"Rabindranath","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Dingwall, K.M., Nagel, T., Hughes, J.T., Kavanagh, D.J., Cass, A., Howard, K., Sweet, M., Brown, S., Sajiv, C., and Majoni, S.W. (2019). Wellbeing intervention for chronic kidney disease (WICKD): A randomised controlled trial study protocol. BMC Psychol., 7.","DOI":"10.1186\/s40359-018-0264-x"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0140-6736(99)01376-8","article-title":"Impact of sleep debt on metabolic and endocrine function","volume":"354","author":"Spiegel","year":"1999","journal-title":"Lancet"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1530\/JOE-21-0155","article-title":"The links between sleep duration, obesity and type 2 diabetes mellitus","volume":"252","author":"Antza","year":"2021","journal-title":"J. Endocrinol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.metabol.2018.02.010","article-title":"Sleep influences on obesity, insulin resistance, and risk of type 2 diabetes","volume":"84","author":"Reutrakul","year":"2018","journal-title":"Metabolism"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000358858","article-title":"The important role of sleep in metabolism","volume":"42","author":"Copinschi","year":"2014","journal-title":"Front. Horm. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jcjd.2013.02.060","article-title":"Inadequate sleep as a contributor to obesity and type 2 diabetes","volume":"37","author":"McNeil","year":"2013","journal-title":"Can. J. Diabetes"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.2147\/DMSO.S354026","article-title":"Sleep and Circadian Rhythm Disturbances in Diabetes: A Narrative Review","volume":"15","author":"Rutters","year":"2022","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_82","first-page":"CD012625","article-title":"Interventions for improving sleep quality in people with chronic kidney disease","volume":"5","author":"Natale","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1111\/bph.14116","article-title":"New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation","volume":"175","author":"Zisapel","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1111\/bph.14371","article-title":"Recent developments in research of melatonin and its potential therapeutic applications","volume":"175","author":"Stanford","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"ref_85","first-page":"575","article-title":"Melatonin in sleep disorders","volume":"37","author":"Poza","year":"2022","journal-title":"Neurologia (Engl. Ed.)"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2165\/00023210-200721120-00004","article-title":"Role of the melatonin system in the control of sleep: Therapeutic implications","volume":"21","author":"Srinivasan","year":"2007","journal-title":"CNS Drugs"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/00207450802328607","article-title":"Melatonin and melatonergic drugs on sleep: Possible mechanisms of action","volume":"119","author":"Srinivasan","year":"2009","journal-title":"Int. J. Neurosci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ncpneuro0467","article-title":"Drug Insight: The use of melatonergic agonists for the treatment of insomnia-focus on ramelteon","volume":"3","author":"Srinivasan","year":"2007","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3109\/07420528.2015.1048868","article-title":"An observational study on disturbed peripheral circadian rhythms in hemodialysis patients","volume":"32","author":"Russcher","year":"2015","journal-title":"Chronobiol. Int."},{"key":"ref_90","first-page":"653","article-title":"Decreased melatonin nocturnal concentrations in hemodialyzed patients","volume":"26","author":"Karasek","year":"2005","journal-title":"Neuroendocr. Endocrinol. Lett."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/01616412.2017.1315864","article-title":"A review of sleep disorders and melatonin","volume":"39","author":"CXie","year":"2017","journal-title":"Neurol. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1111\/bph.14365","article-title":"Modulation of serine\/threonine phosphatases by melatonin: Therapeutic approaches in neurodegenerative diseases","volume":"175","author":"Arribas","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/bmj.332.7538.373","article-title":"Does melatonin help people sleep?","volume":"332","author":"Herxheimer","year":"2006","journal-title":"BMJ"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4103\/0971-4065.114488","article-title":"Melatonin improves sleep quality in hemodialysis patients","volume":"23","author":"Haqhverdi","year":"2013","journal-title":"Indian J. Nephrol."},{"key":"ref_95","first-page":"1","article-title":"Melatonin for treatment of sleep disorders","volume":"108","author":"Buscemi","year":"2004","journal-title":"Evid. Rep. Technol. Assess. (Summ.)"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.smrv.2004.06.004","article-title":"Effects of exogenous melatonin on sleep: A meta-analysis","volume":"9","author":"Brzezinski","year":"2005","journal-title":"Sleep Med. Rev."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.semnephrol.2015.06.007","article-title":"Insomnia in Patients With Chronic Kidney Disease","volume":"35","author":"Lindner","year":"2015","journal-title":"Semin. Nephrol."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Gombert, M., and Codo\u00f1er-Franch, P. (2021). Melatonin in Early Nutrition: Long-Term Effects on Cardiovascular System. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22136809"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"119851","DOI":"10.1016\/j.lfs.2021.119851","article-title":"The role of sleep disorders in cardiovascular diseases: Culprit or accomplice?","volume":"283","author":"Wang","year":"2021","journal-title":"Life Sci."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsmc.2016.10.012","article-title":"Sleep, Health, and Society","volume":"12","author":"Grandner","year":"2017","journal-title":"Sleep Med. Clin."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.autneu.2019.02.006","article-title":"Sleep disorders, nocturnal blood pressure, and cardiovascular risk: A translational perspective","volume":"218","author":"Silvani","year":"2019","journal-title":"Auton. Neurosci."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.2174\/1381612821666150706105926","article-title":"Disruption of Circadian Rhythms and Sleep on Critical Illness and the Impact on Cardiovascular Events","volume":"21","author":"Reitz","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/14737175.2018.1489239","article-title":"Sleep disorders and the risk of stroke","volume":"18","author":"McDermott","year":"2018","journal-title":"Expert Rev. Neurother."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/01.STR.20.4.473","article-title":"Morning increase in onset of ischemic stroke","volume":"20","author":"Marler","year":"1989","journal-title":"Stroke"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1172\/JCI80590","article-title":"Role of the circadian system in cardiovascular disease","volume":"128","author":"Thosar","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1161\/CIRCRESAHA.114.302995","article-title":"Short-term disruption of diurnal rhythms after murine myocardial infarction adversely affects long-term myocardial structure and function","volume":"114","author":"Alibhai","year":"2014","journal-title":"Circ. Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.2174\/1381612821666150706111504","article-title":"Disruption of Circadian Rhythms and Sleep in Critical Illness: Potential Implications for Angiogenesis After Myocardial Infarction. A Review","volume":"21","author":"Sun","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/hr.2016.9","article-title":"Circadian clock and the onset of cardiovascular events","volume":"39","author":"Takeda","year":"2016","journal-title":"Hypertens. Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e12418","DOI":"10.1111\/jpi.12418","article-title":"Melatonin protects against diabetic cardiomyopathy through Mst1\/Sirt3 signaling","volume":"63","author":"Zhang","year":"2017","journal-title":"J. Pineal Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2174\/187152907781745297","article-title":"Melatonin in cardiac ischemia\/reperfusion-induced mitochondrial adaptive changes","volume":"7","author":"Giacomo","year":"2007","journal-title":"Cardiovasc. Hematol. Disord. Drug Targets"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1096\/fj.05-4692com","article-title":"Protective effect of melatonin against mitochondrial dysfunction associated with cardiac ischemia- reperfusion: Role of cardiolipin","volume":"20","author":"Petrosillo","year":"2006","journal-title":"FASEB J."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/MOL.0000000000000314","article-title":"Effects of melatonin on cardiovascular diseases: Progress in the past year","volume":"27","author":"Sun","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e12686","DOI":"10.1111\/jpi.12686","article-title":"Melatonin ameliorates PM2.5 -induced cardiac perivascular fibrosis through regulating mitochondrial redox homeostasis","volume":"70","author":"Jiang","year":"2021","journal-title":"J. Pineal Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1182\/blood-2013-09-512749","article-title":"Oxidative stress in angiogenesis and vascular disease","volume":"123","author":"Kim","year":"2014","journal-title":"Blood"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"5853238","DOI":"10.1155\/2017\/5853238","article-title":"Oxidative Stress and Inflammation in Cardiovascular Disease","volume":"2017","author":"Zazueta","year":"2017","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1525-139X.2003.16025.x","article-title":"Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis","volume":"16","author":"Levin","year":"2003","journal-title":"Semin. Dial."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1046\/j.1523-1755.1999.00773.x","article-title":"Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency","volume":"56","author":"Culleton","year":"1999","journal-title":"Kidney Int."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1089\/152308602762197470","article-title":"Evolution of oxidative stress and inflammation during hemodialysis and their contribution to cardiovascular disease","volume":"4","author":"Wratten","year":"2002","journal-title":"Antioxid. Redox Signal."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1161\/ATVBAHA.119.312705","article-title":"Atherosclerosis in Chronic Kidney Disease: More, Less, or Just Different?","volume":"39","author":"Valdivielso","year":"2019","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.vph.2015.03.005","article-title":"The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review)","volume":"71","author":"Siti","year":"2015","journal-title":"Vascul. Pharmacol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fphys.2020.00103","article-title":"Sirtuin1 Role in the Melatonin Protective Effects Against Obesity-Related Heart Injury","volume":"11","author":"Favero","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"888319","DOI":"10.3389\/fcvm.2022.888319","article-title":"Evidence for the Benefits of Melatonin in Cardiovascular Disease","volume":"9","author":"Tobeiha","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1681\/ASN.2014070714","article-title":"Alberta Kidney Disease Network. Cause of Death in Patients with Reduced Kidney Function","volume":"26","author":"Thompson","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e14688","DOI":"10.14814\/phy2.14688","article-title":"Genetic susceptibility of hypertension-induced kidney disease","volume":"9","author":"Zhang","year":"2021","journal-title":"Physiol. Rep."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/jhh.2013.55","article-title":"Hypertension and kidneys: Unraveling complex molecular mechanisms underlying hypertensive renal damage","volume":"28","author":"Mennuni","year":"2014","journal-title":"J. Hum. Hypertens."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.ajkd.2018.12.044","article-title":"Hypertension in CKD: Core Curriculum 2019","volume":"74","author":"Ku","year":"2019","journal-title":"Am. J. Kidney Dis."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1159\/000525441","article-title":"The Role of Melatonin in Chronic Kidney Disease and Its Associated Risk Factors: A New Tool in Our Arsenal?","volume":"53","author":"Theofilis","year":"2022","journal-title":"Am. J. Nephrol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1034\/j.1600-0773.2000.d01-23.x","article-title":"Hypotensive activity of the pineal indoleamine hormones melatonin, 5-methoxytryptophol and 5-methoxytryptamine","volume":"86","author":"Wang","year":"2000","journal-title":"Pharmacol. Toxicol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"9286458","DOI":"10.1155\/2018\/9286458","article-title":"Melatonin Ameliorates the Progression of Atherosclerosis via Mitophagy Activation and NLRP3 Inflammasome Inhibition","volume":"2018","author":"Ma","year":"2018","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"11363","DOI":"10.18632\/aging.202829","article-title":"Melatonin attenuates smoking-induced atherosclerosis by activating the Nrf2 pathway via NLRP3 inflammasomes in endothelial cells","volume":"13","author":"Zhao","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"106072","DOI":"10.1016\/j.phrs.2022.106072","article-title":"Melatonin-based therapeutics for atherosclerotic lesions and beyond: Focusing on macrophage mitophagy","volume":"176","author":"Ajoolabady","year":"2022","journal-title":"Pharm. Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/00365590410031715","article-title":"Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease","volume":"38","author":"Yao","year":"2004","journal-title":"Scand. J. Urol. Nephrol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1681\/ASN.2011111115","article-title":"Cardiovascular disease in children with chronic kidney disease","volume":"23","author":"Mitsnefes","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e12449","DOI":"10.1111\/jpi.12449","article-title":"Melatonin prevents endothelial cell pyroptosis via regulation of long noncoding RNA MEG3\/miR-223\/NLRP3 axis","volume":"64","author":"Zhang","year":"2018","journal-title":"J. Pineal Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.atherosclerosis.2018.08.046","article-title":"CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies","volume":"278","author":"Reiss","year":"2018","journal-title":"Atherosclerosis"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/ndt\/17.suppl_8.33","article-title":"Inflammation in end-stage renal failure: Could it be treated?","volume":"17","author":"Stenvinkel","year":"2002","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_138","first-page":"65","article-title":"Obesity and kidney disease","volume":"39","author":"Bentes","year":"2017","journal-title":"J. Bras. Nefrol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.semnephrol.2012.12.008","article-title":"The adipose tissue as an endocrine organ","volume":"33","author":"Adamczak","year":"2013","journal-title":"Semin. Nephrol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"273","DOI":"10.23736\/S0391-1977.19.03015-3","article-title":"Management of diabetes mellitus in chronic kidney disease","volume":"44","author":"Garla","year":"2019","journal-title":"Minerva Endocrinol."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Busch, M., Nadal, J., Schmid, M., Paul, K., Titze, S., H\u00fcbner, S., K\u00f6ttgen, A., Schultheiss, U.T., Baid-Agrawal, S., and Lorenzen, J. (2016). Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease\u2014Cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort. BMC Nephrol., 17.","DOI":"10.1186\/s12882-016-0273-z"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s00508-010-1409-y","article-title":"Increased proinflammatory cytokine production in adipose tissue of obese patients with chronic kidney disease","volume":"122","author":"Teplan","year":"2010","journal-title":"Wien. Klin. Wochenschr."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.nut.2008.12.012","article-title":"Increased production of proinflammatory cytokines in adipose tissue of patients with end-stage renal disease","volume":"25","author":"Roubicek","year":"2009","journal-title":"Nutrition"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/biof.1637","article-title":"The roles of melatonin on kidney injury in obese and diabetic conditions","volume":"46","author":"Promsan","year":"2020","journal-title":"Biofactors"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/biof.1690","article-title":"Ischemic stroke, obesity, and the anti-inflammatory role of melatonin","volume":"47","author":"Yawoot","year":"2021","journal-title":"Biofactors"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11906-018-0842-6","article-title":"Anti-Inflammatory Effects of Melatonin in Obesity and Hypertension","volume":"20","author":"Prado","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Wang, M., Wang, Z., Chen, Y., and Dong, Y. (2022). Kidney Damage Caused by Obesity and Its Feasible Treatment Drugs. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23020747"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1600-079X.2004.00122.x","article-title":"Melatonin reduces cholesterol accumulation and prooxidant state induced by high cholesterol diet in the plasma, the liver and probably in the aorta of C57BL\/6J mice","volume":"36","author":"Sener","year":"2004","journal-title":"J. Pineal Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0021-9150(88)90023-8","article-title":"Effects of melatonin on genetic hypercholesterolemia in rats","volume":"69","author":"Aoyama","year":"1988","journal-title":"Atherosclerosis"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Guan, Q., Wang, Z., Cao, J., Dong, Y., and Chen, Y. (2021). Mechanisms of Melatonin in Obesity: A Review. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010218"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"e12524","DOI":"10.1111\/jpi.12524","article-title":"Melatonin reprogramming of gut microbiota improves lipid dysmetabolism in high-fat diet-fed mice","volume":"65","author":"Yin","year":"2018","journal-title":"J. Pineal Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"4531865","DOI":"10.1155\/2019\/4531865","article-title":"The Mystery behind the Pineal Gland: Melatonin Affects the Metabolism of Cholesterol","volume":"2019","author":"Karolczak","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1039\/C3SM52064A","article-title":"Melatonin directly interacts with cholesterol and alleviates cholesterol effects in dipalmitoylphosphatidylcholine monolayers","volume":"10","author":"Choi","year":"2014","journal-title":"Soft Matter"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.bbamem.2013.05.015","article-title":"Effect of melatonin and cholesterol on the structure of DOPC and DPPC membranes","volume":"1828","author":"Drolle","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.tem.2019.11.011","article-title":"Melatonin Effects on Glucose Metabolism: Time To Unlock the Controversy","volume":"31","author":"Garaulet","year":"2020","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41574-018-0130-1","article-title":"Melatonin in type 2 diabetes mellitus and obesity","volume":"15","author":"Karamitri","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s11892-012-0327-y","article-title":"Tired of diabetes genetics? Circadian rhythms and diabetes: The MTNR1B story?","volume":"12","author":"Nagorny","year":"2012","journal-title":"Curr. Diab. Rep."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1210\/me.2014-1293","article-title":"Activation of Melatonin Signaling Promotes \u03b2-Cell Survival and Function","volume":"29","author":"Costes","year":"2015","journal-title":"Mol. Endocrinol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejphar.2014.08.012","article-title":"Melatonin receptors in diabetes: A potential new therapeutical target?","volume":"744","author":"She","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.biochi.2022.01.001","article-title":"Diabetes mellitus and melatonin: Where are we?","volume":"202","author":"Patel","year":"2022","journal-title":"Biochimie"},{"key":"ref_161","first-page":"1","article-title":"A new prospective on the role of melatonin in diabetes and its complications","volume":"40","author":"Mok","year":"2019","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/ki.2014.49","article-title":"The etiology of glomerulonephritis: Roles of infection and autoimmunity","volume":"86","author":"Couser","year":"2014","journal-title":"Kidney Int."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Oliveira, C.B., Lima, C.A.D., Vajgel, G., and Sandrin-Garcia, P. (2021). The Role of NLRP3 Inflammasome in Lupus Nephritis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222212476"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.intimp.2018.10.025","article-title":"Piperine ameliorated lupus nephritis by targeting AMPK-mediated activation of NLRP3 inflammasome","volume":"65","author":"Peng","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Bonomini, F., Dos Santos, M., Veronese, F.V., and Rezzani, R. (2019). NLRP3 Inflammasome Modulation by Melatonin Supplementation in Chronic Pristane-Induced Lupus Nephritis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20143466"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.lfs.2017.10.038","article-title":"Oral supplementation of melatonin protects against lupus nephritis renal injury in a pristane-induced lupus mouse model","volume":"193","author":"Favero","year":"2018","journal-title":"Life Sci."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2019.07.002","article-title":"Potential role of melatonin in autoimmune diseases","volume":"48","author":"Zhao","year":"2019","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nrneph.2014.216","article-title":"Causes and pathogenesis of focal segmental glomerulosclerosis","volume":"11","author":"Fogo","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_169","first-page":"1941038","article-title":"Decoding the Mechanism behind the Pathogenesis of the Focal Segmental Glomerulosclerosis","volume":"2022","author":"Zhu","year":"2022","journal-title":"Comput. Math Methods Med."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1600-079X.2011.00960.x","article-title":"Melatonin enhances endogenous heme oxygenase-1 and represses immune responses to ameliorate experimental murine membranous nephropathy","volume":"52","author":"Wu","year":"2012","journal-title":"J. Pineal Res."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1007\/s00330-017-5246-5","article-title":"Post-contrast acute kidney injury\u2014Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors: Recommendations for updated ESUR Contrast Medium Safety Committee guidelines","volume":"28","author":"Reimer","year":"2018","journal-title":"Eur. Radiol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12928-020-00660-8","article-title":"Contrast-induced acute kidney injury","volume":"35","author":"Chandiramani","year":"2020","journal-title":"Cardiovasc. Interv. Ther."},{"key":"ref_173","first-page":"293","article-title":"Pathophysiology of Contrast-Induced Acute Kidney Injury","volume":"9","author":"Bansal","year":"2020","journal-title":"Interv. Cardiol. Clin."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"118379","DOI":"10.1016\/j.lfs.2020.118379","article-title":"Advances in the pathogenesis and prevention of contrast-induced nephropathy","volume":"259","author":"Zhang","year":"2020","journal-title":"Life Sci."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.2174\/1381612825666191210152944","article-title":"Pathophysiology of Contrast-Induced Acute Kidney Injury (CIAKI)","volume":"25","author":"Vlachopanos","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2174\/1389203717666160909125004","article-title":"The Update of NGAL in Acute Kidney Injury","volume":"18","author":"Shang","year":"2017","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"6668887","DOI":"10.1155\/2021\/6668887","article-title":"Melatonin Alleviates Contrast-Induced Acute Kidney Injury by Activation of Sirt3","volume":"2021","author":"Zhang","year":"2021","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.ajkd.2016.07.033","article-title":"Comparative Effectiveness of 12 Treatment Strategies for Preventing Contrast-Induced Acute Kidney Injury: A Systematic Review and Bayesian Network Meta-analysis","volume":"69","author":"Su","year":"2017","journal-title":"Am. J. Kidney Dis."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s40620-018-0498-y","article-title":"Contrast medium induced acute kidney injury: A narrative review","volume":"31","author":"Pistolesi","year":"2018","journal-title":"J. Nephrol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10557-016-6683-0","article-title":"Prevention of Contrast-Induced Acute Kidney Injury: An Update","volume":"30","author":"Chaikias","year":"2016","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cccn.2004.09.005","article-title":"Drug-induced renal failure: A focus on tubulointerstitial disease","volume":"351","author":"Markowitz","year":"2005","journal-title":"Clin. Chim. Acta"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.2215\/CJN.00150118","article-title":"Pharmacology behind Common Drug Nephrotoxicities","volume":"13","author":"Perazella","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_183","first-page":"970","article-title":"Drug-induced kidney diseases","volume":"51","author":"Singh","year":"2003","journal-title":"J. Assoc. Physicians India"},{"key":"ref_184","first-page":"3","article-title":"Drug-induced acute interstitial nephritis: Pathology, pathogenesis, and treatment","volume":"9","author":"Krishnan","year":"2015","journal-title":"Iran. J. Kidney Dis."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.semnephrol.2010.09.005","article-title":"Nephrotoxicity from chemotherapeutic agents: Clinical manifestations, pathobiology, and prevention\/therapy","volume":"30","author":"Perazella","year":"2010","journal-title":"Semin. Nephrol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2215\/CJN.02050309","article-title":"Renal vulnerability to drug toxicity","volume":"4","author":"Perazella","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/01913120252959254","article-title":"Cyclosporine A-induced kidney alterations are limited by melatonin in rats: An electron microscope study","volume":"26","author":"Stacchiotti","year":"2002","journal-title":"Ultrastruct. Pathol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/jpi.12302","article-title":"Melatonin: The dawning of a treatment for fibrosis?","volume":"60","author":"Hu","year":"2016","journal-title":"J. Pineal Res."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1002\/ptr.6391","article-title":"Rutin attenuates vancomycin-induced renal tubular cell apoptosis via suppression of apoptosis, mitochondrial dysfunction, and oxidative stress","volume":"33","author":"Qu","year":"2019","journal-title":"Phytother. Res."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"e0046221","DOI":"10.1128\/AAC.00462-21","article-title":"Renoprotective Effects of Melatonin against Vancomycin-Related Acute Kidney Injury in Hospitalized Patients: A Retrospective Cohort Study","volume":"65","author":"Hong","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"153202","DOI":"10.1016\/j.phymed.2020.153202","article-title":"7-Hydroxycoumarin protects against cisplatin-induced acute kidney injury by inhibiting necrotosis and promoting Sox9-mediated tubular epithelial cell proliferation","volume":"69","author":"Wu","year":"2020","journal-title":"Phytomedicine"},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Kim, J.W., Jo, J., Kim, J.Y., Choe, M., Leem, J., and Park, J.H. (2019). Melatonin Attenuates Cisplatin-Induced Acute Kidney Injury through Dual Suppression of Apoptosis and Necroptosis. Biology, 8.","DOI":"10.3390\/biology8030064"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.7314\/APJCP.2012.13.8.4101","article-title":"Protective effect of melatonin against radiation induced nephrotoxicity in rats","volume":"13","author":"Kucuktulu","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/108925320400800305","article-title":"Renal insufficiency after cardiac surgery","volume":"8","author":"Garwood","year":"2004","journal-title":"Semin. Cardiothorac. Vasc. Anesth."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"194","DOI":"10.7326\/0003-4819-128-3-199802010-00005","article-title":"Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group","volume":"128","author":"Mangano","year":"1998","journal-title":"Ann. Intern. Med."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/ki.1978.31","article-title":"Tubular leakage and obstruction after renal ischemia: Structural-functional correlations","volume":"13","author":"Donohoe","year":"1978","journal-title":"Kidney Int."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"12324","DOI":"10.1096\/fj.202001252R","article-title":"Melatonin pretreatment alleviates renal ischemia-reperfusion injury by promoting autophagic flux via TLR4\/MyD88\/MEK\/ERK\/mTORC1 signaling","volume":"34","author":"Yang","year":"2020","journal-title":"FASEB J."},{"key":"ref_198","first-page":"e21661","article-title":"Combined tacrolimus and melatonin effectively protected kidney against acute ischemia-reperfusion injury","volume":"35","author":"Yang","year":"2021","journal-title":"FASEB J."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"791036","DOI":"10.3389\/fphys.2021.791036","article-title":"Protective Effect of Melatonin for Renal Ischemia-Reperfusion Injury: A Systematic Review and Meta-Analysis","volume":"12","author":"Dun","year":"2022","journal-title":"Front. Physiol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/iju.14345","article-title":"Combination therapy with melatonin, stem cells and extracellular vesicles is effective in limiting renal ischemia-reperfusion injury in a rat model","volume":"27","author":"Zahran","year":"2020","journal-title":"Int. J. Urol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"101241","DOI":"10.1016\/j.trim.2019.101241","article-title":"The effect of oral melatonin on renal ischemia-reperfusion injury in transplant patients: A double-blind, randomized controlled trial","volume":"57","author":"Panah","year":"2019","journal-title":"Transpl. Immunol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/08860220701391738","article-title":"The protective effects of melatonin and vitamin E against renal ischemia-reperfusion injury in rats","volume":"29","author":"Aktoz","year":"2007","journal-title":"Ren. Fail."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/6\/838\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:50:51Z","timestamp":1760122251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/6\/838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,8]]},"references-count":202,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["cells12060838"],"URL":"https:\/\/doi.org\/10.3390\/cells12060838","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,8]]}}}